Visiting Speaker
Ahmed Alkhateeb
Fellow at Flagship Pioneering Ventures and founder of Hive Scientific
Addressing the irreproducibility crisis in biomedicine through human-computer interactions
Thursday
Jul 6, 2017
Watch video
2:00 pm
177 Huntington Ave
11th floor

The Irreproduciblity crisis in the biomedical literature threatens to undermine trust in the scientific enterprise. Analyses performed in the pharmaceutical industry estimate that 80-90% of the published biomedical literature cannot be independently reproduced. This problem is magnified by the fact that we produce over a million new biomedical research papers a year. Hive Scientific addresses this problem through (1) the construction of a comprehensive knowledge network of all empirical findings  through crowdsourcing, and (2) the development of objective confidence metrics that enable scientists, funding agencies, and pharmaceutical companies to distinguish between robust and weak science.  

About the speaker
Ahmed Alkhateeb completed his PhD in molecular biology from Penn State College of Medicine and his postdoctoral training at Harvard Medical School. He is currently a fellow at Flagship Pioneering Ventures and the founder of Hive Scientific, a data analytics startup that addresses the uncertainty of the irreproduciblity crisis in biotech investment and pharma business development.

No upcoming events

View all
Visiting Speaker
Ahmed Alkhateeb
Fellow at Flagship Pioneering Ventures and founder of Hive Scientific
Addressing the irreproducibility crisis in biomedicine through human-computer interactions
Thu
Jul 6, 2017
2:00 pm
177 Huntington Ave
11th floor
ADD to calendar

The Irreproduciblity crisis in the biomedical literature threatens to undermine trust in the scientific enterprise. Analyses performed in the pharmaceutical industry estimate that 80-90% of the published biomedical literature cannot be independently reproduced. This problem is magnified by the fact that we produce over a million new biomedical research papers a year. Hive Scientific addresses this problem through (1) the construction of a comprehensive knowledge network of all empirical findings  through crowdsourcing, and (2) the development of objective confidence metrics that enable scientists, funding agencies, and pharmaceutical companies to distinguish between robust and weak science.  

about the speaker
Ahmed Alkhateeb completed his PhD in molecular biology from Penn State College of Medicine and his postdoctoral training at Harvard Medical School. He is currently a fellow at Flagship Pioneering Ventures and the founder of Hive Scientific, a data analytics startup that addresses the uncertainty of the irreproduciblity crisis in biotech investment and pharma business development.

No upcoming events